Public and Scientific Affairs Board

Public and Scientific Affairs Board

On Friday, September 14, The Pew Charitable Trusts hosted FDA Commissioner Scott Gottlieb announced the agency’s approach to reducing antimicrobial resistance (AMR) through antibiotic stewardship and innovation. 

The Centers for Medicare and Medicaid Services (CMS) subcontractor Palmetto MolDX has finalized its Local Coverage Determination (LCD) for Multiplex Nucleic Acid Amplified Tests (NAATs) for Respiratory Viral Panels.

The American Clinical Laboratory Association (ACLA), a trade association representing clinical laboratories, challenged a regulation issued by the Secretary of the U.S. Department of Health and Human Services (DHHS), specifically, Section 216 of the Protecting Access to Medicare Act of 2014 (“PAMA”).

ASM applauds the House on passing the FY19 Labor-HHS Bill, which includes a $2 billion increase for the National Institutes of Health (NIH) and an increase of $127 million for the Centers for Disease Control and Prevention.

We urge House members to vote in favor of the bill and encourage swift Senate passage of the bill, including the PACCARB provision.

VITEK 2 Gram-Positive AST Cards Recalled Due to False Results for Some MRSA Strains: What Can Your Laboratory Do?

The report provides the most recent nationwide data on antibiotic resistance transmitted commonly by food.

Thursday, 23 August 2018 09:54

ASM Attends CPT® Editorial Panel Meeting

Coding and Reimbursement subcommittee member Amy Peace-Brewer represented ASM at the Current Procedural Terminology (CPT®) Editorial Panel on August 9.

ASM joined organizations representing laboratories, diagnostic manufacturers, health care professionals, and patients to urge Congress to take immediate action to address the harmful cuts to the Clinical Laboratory Fee Schedule (CLFS).

On July 26, ASM joined the Clinical Laboratory Coalition (CLC) in a conference call to update members on current strategies to reverse the detrimental effects of the Protecting Access to Medicare Act of 2014 (PAMA) legislation, which will reduce laboratory test reimbursement.

Page 1 of 12